
U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.
Shares of Taysha Gene Therapies Inc (NASDAQ:TSHA) rose sharply during Thursday's session after the FDA granted the company Breakthrough Therapy designation to TSHA-102 for the treatment of Rett syndrome.